GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LENZ Therapeutics Inc (NAS:LENZ) » Definitions » Total Equity

LENZ (LENZ Therapeutics) Total Equity : $204.08 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is LENZ Therapeutics Total Equity?

LENZ Therapeutics's total equity for the quarter that ended in Dec. 2024 was $204.08 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


LENZ Therapeutics Total Equity Historical Data

The historical data trend for LENZ Therapeutics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LENZ Therapeutics Total Equity Chart

LENZ Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Total Equity
-14.21 -24.17 -92.71 204.08

LENZ Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -92.71 198.17 192.92 215.28 204.08

LENZ Therapeutics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

LENZ Therapeutics's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=215.304-11.22
=204.08

LENZ Therapeutics's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=215.304-11.22
=204.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LENZ Therapeutics Total Equity Related Terms

Thank you for viewing the detailed overview of LENZ Therapeutics's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


LENZ Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
445 Marine View Avenue, STE No. 320, Del Mar, CA, USA, 92014
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.